News

Article

NFL Hall-of-Famer OJ Simpson Dies of Prostate Cancer

Author(s):

The former NFL player, O.J. Simpson, died of cancer at the age of 76, according to a family statement.

Photo Credits: Steve Marcus/UPI/Shutterstock.com

O.J. Simpson died at age 76 from cancer.

Photo Credits: Steve Marcus/UPI/Shutterstock

O.J. Simpson, football hall-of-famer who was acquitted for murder in 1994, died of cancer, according to a statement from his family.

"On April 10th, our father, Orenthal James Simpson, succumbed to his battle with cancer. He was surrounded by his children and grandchildren. During this time of transition, his family asks that you please respect their wishes for privacy and grace," a statement from his family said.

He was reportedly diagnosed with prostate cancer.

Simpson, who was inducted into the Pro Football Hall of Fame in 1985 after playing for the Buffalo Bills and San Francisco 49ers, was 76 at the time of his death.

He was a running back at the University of Southern California, where he won the Heisman Trophy during his senior year in 1968. In 1969, Simpson was drafted as the first overall draft pick for the Buffalo Bills, where he went All-Pro in 1972 and became the first player to rush for 2,000 yards in 1973.

Two decades later, however, Simpson was accused of murdering his ex-wife, Nicole Brown Simpson. He was found not guilty in October 1995, two years before he was sued in civil court and found liable for the murders. Then, in 2008, he was found guilty of robbery and kidnapping after a 2007 incident where he stole sports memorabilia he believed was stolen from him. He spent nine years in prison.

The football player mentioned a cancer diagnosis in a May 2023 video on X (formerly known as Twitter). Then, in 2024, he posted another video denying allegations that he was in hospice care.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Dr. Valerie Lee discussed emerging targeted therapies and personalized medicine approaches that are showing promise for those with gastrointestinal cancer.
Image of doctor.
Image of smiling doctor.
Although late-stage kidney cancer generated poor survival rates for over two decades, significant progress is being made in the treatment of the disease.
There are a number of reasons why patients with cancer are encouraged to enroll in clinical trials, Dr. Michael J. Pishvaian explained.
Use of NeuroSAFE to guide nerve sparing during robot-assisted radical prostatectomy improved patient-reported erectile function.
Adolescent and Young Adult Cancer Awareness Week sheds light on the financial hardships young cancer survivors face, including debt and limited assistance.
CURE spoke with Dr. William C. Huang about what kind of team may be required to treat a patient with metastatic kidney cancer.
Image of woman.
Image of woman.
Related Content